Mobia Medical completes IPO, adopts amended charter with classified board and exclusive forum provisions

Mobia Medical, Inc.

IPO closed May 11, 2026; authorized common stock increased to 950M shares; 50M shares of undesignated preferred stock authorized.
Board classified into three classes with staggered three-year terms; directors removable only for cause with 2/3 supermajority vote.
Stockholder action by written consent eliminated; advance notice required for director nominations and proposals.
Exclusive forum: Delaware Chancery for internal corporate claims; federal courts for Securities Act claims.
Amended and restated bylaws effective concurrently with charter; procedures for stockholder proposals and nominations established.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Mobia Medical, Inc.: Amended and restated certificate of incorporation upon IPO closing, increasing authorized common stock to 950M shares, eliminating prior preferred stock references, authorizing 50M shares of undesignated preferred stock, establishing classified board with staggered three-year terms, requiring cause (effective 2026-05-11).

Change: charter amendment
Effective: 2026-05-11

Exact text from the filing

On May 11, 2026, Mobia Medical, Inc. (the “Company”) filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the closing of the initial public offering (the “IPO”) of shares of its common stock.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Mobia Medical, Inc.: Amended and restated bylaws effective upon IPO closing, establishing procedures for stockholder proposals and director nominations, and conforming to the restated certificate (effective 2026-05-11).

Change: bylaw amendment
Effective: 2026-05-11

Exact text from the filing

On May 11, 2026, in connection with the closing of the IPO, the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), previously approved by the Company’s board of directors to become effective upon the effectiveness of the Restated Certificate, became effective.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Mobia Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-033685

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.